In addition to serving as the company’s General Counsel he is also a partner and the immediate past chairman of Lippes Mathias LLP, law firm, Co-Founder and Managing Director of Varia …

These include a survivin mono-clonal antibody platform with potential to target survivin-expressing cancers as well as autoimmune diseases such as myasthenia gravis. Also, a sur-vivin …

Jan 9, 2024 · Varia’s platform blends insights from key opinion leaders, strategic partners, and industry experts through its “end-to-end” technology solution designed to support early stage …